Answers are grounded in this paper and cite their sources.
These results suggest a potential benefit of initial combination therapy on glycaemic outcomes in diabetes compared to metformin monotherapy across a wide range of baseline A1c levels. Further research should explore if early combination treatment may also affect longer term health outcomes in diabetes.
No takes yet. Share an insight, caveat, or question.
Phung et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: